GlobeImmune Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Net Income before Extraordinaries
13,724.80
2,014.70
9,476.70
16,260.90
2,766.90
Depreciation, Depletion & Amortization
952.10
925.50
771.30
295.20
187.30
Other Funds
1,864.10
1,582.30
1,623.60
10,442.30
7.40
Funds from Operations
10,908.60
2,671.60
8,624.40
5,523.50
2,587.00
Changes in Working Capital
5,903.60
10,396.50
4,692.70
4,527.60
4,542.70
Net Operating Cash Flow
5,005.00
13,068.00
3,931.70
10,051.10
7,129.70
Capital Expenditures
132.80
108.80
12.20
294.20
35.70
Sale of Fixed Assets & Businesses
-
-
-
127.40
253.70
Net Investing Cash Flow
132.80
108.80
12.20
166.80
218.00
Issuance/Reduction of Debt, Net
-
-
-
6,448.50
-
Net Financing Cash Flow
1.00
25.20
1.80
21,106.20
-
Net Change in Cash
5,136.80
13,151.70
3,921.30
10,888.20
6,911.70
Free Cash Flow
5,137.80
13,176.90
3,919.50
10,345.30
7,165.40
Change in Capital Stock
1.00
25.20
1.80
14,657.60
-
About GlobeImmune
View Profile
